Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5774893

CCN(CC)CCCNC(=O)CCc1cnoc1-c1ccc(F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
LMNA P02545 5/20 0.40
ALDH1A1 P00352 3/20 0.40
HTT P42858 3/20 0.40
MAPT P10636 2/20 0.40
ALOX15 P16050 1/20 0.40
KMT2A Q03164 3/20 0.39
MEN1 O00255 2/20 0.39
HDAC4 P56524 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
ACKR3 P25106 1/20 0.38
TSHR P16473 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
MAPK1 P28482 1/20 0.37
NPC1 O15118 1/20 0.36
TP53 P04637 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5777271 0.92 GAA (0.37) GAALMNAALDH1A1HTTMAPT
Trifluoroacetic Acid SCHEMBL5777437 0.87 ACKR3 (0.41) LMNAALDH1A1HTTMAPTALOX15
Trifluoroacetic Acid SCHEMBL5774082 0.87 ACKR3 (0.42) GAALMNAALDH1A1HTTMAPT
Trifluoroacetic Acid SCHEMBL5774050 0.84 TRPV1 (0.43) GAALMNAALDH1A1HTTMAPT
SCHEMBL5773408 0.83 LMNA (0.48) LMNAHTTHDAC4HDAC6TSHR
SCHEMBL5777275 0.82 LMNA (0.33) GAALMNAALDH1A1HTTMAPT
Trifluoroacetic Acid SCHEMBL5774671 0.81 MAPT (0.54) LMNAALDH1A1HTTMAPTALOX15
Trifluoroacetic Acid SCHEMBL5773355 0.81 TSHR (0.50) GAALMNAALDH1A1HTTKMT2A
Trifluoroacetic Acid SCHEMBL5774844 0.81 HDAC4 (0.40) GAALMNAALDH1A1KMT2AMEN1
Trifluoroacetic Acid SCHEMBL5773631 0.81 POLB (0.48) LMNAHTTALOX15KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR GAA 2207/4885LMNA 2770/4885ALDH1A1 1045/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 GAA 1930/4885LMNA 2605/4885ALDH1A1 682/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.